387570 — Finemedix Co Income Statement
0.000.00%
Last trade - 00:00- KR₩44bn
- KR₩42bn
- KR₩10bn
Annual income statement for Finemedix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 7,254 | 8,142 | 10,154 | 9,960 |
| Cost of Revenue | ||||
| Gross Profit | 3,443 | 4,406 | 5,640 | 5,705 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 9,559 | 9,003 | 9,281 | 9,990 |
| Operating Profit | -2,306 | -861 | 874 | -29.2 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -2,200 | 294 | 1,178 | -206 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1,543 | 240 | 1,176 | -24.2 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -1,410 | 240 | 1,176 | -24.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -1,410 | 240 | 1,176 | -24.2 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -275 | 182 | 326 | 99.9 |
| Dividends per Share |